Develops and sells antibody medicines for people with autoimmune diseases.
20-F for FY2025, filed Mar 19, 2026
Public health institutions and government entities buy products through specialty distributors.
20-F for FY2025, filed Mar 19, 2026Chargebacks: Chargebacks are discounts that occur in multiple jurisdictions globally, whereby contracted parties purchase directly from a…View ↗
Yes. It kept 31 cents of every revenue dollar as net income in FY2025 and turned 16 cents into free cash flow.
Loading...